Current Graphene Science (Discontinued)
Title:Meet Our Editorial Board Member
Volume: 2 Issue: 1
Author(s): H.P. de Oliveira
Affiliation:
Export Options
About this article
Cite this article as:
de Oliveira H.P. , Meet Our Editorial Board Member, Current Graphene Science (Discontinued) 2018; 2 (1) . https://dx.doi.org/10.2174/245227320201181009122212
DOI https://dx.doi.org/10.2174/245227320201181009122212 |
Print ISSN 2452-2732 |
Publisher Name Bentham Science Publisher |
Online ISSN 2452-2740 |
15
3
Related Articles
-
Endocrine-Disrupting Compounds in Fish Physiology, with Emphasis on
their Effects on the Arginine Vasotocin/Isotocin System
Endocrine, Metabolic & Immune Disorders - Drug Targets Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
Current Nanomedicine Polyphenols and Neuroprotection against Ischemia and Neurodegeneration
Mini-Reviews in Medicinal Chemistry Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies
CNS & Neurological Disorders - Drug Targets Glucose Sensors Based on Core@Shell Magnetic Nanomaterials and Their Application in Diabetes Management: A Review
Current Pharmaceutical Design Oil-based Formulation as a Sustained-Released Injection for a Novel Synthetic Peptide
Current Pharmaceutical Biotechnology Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry New Aspects in Sustained Drug Release Formulations
Recent Patents on Drug Delivery & Formulation Morphological Characteristics, Geographical Distribution, Secondary Metabolites, and Biological Activities of Taxus
Mini-Reviews in Organic Chemistry Spoligotyping for Identification of Pulmonary Tuberculosis with Type 2 Diabetes Mellitus Profiles in Warangal, T.S.
Anti-Infective Agents A Novel Approach to Anticancer Therapies: Peroxisome Proliferator Activator-Receptor-γ as a New Target Therapy in the Treatment of Human Urological Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals
Current Neuropharmacology HSF1, A Versatile Factor in Tumorogenesis
Current Molecular Medicine Nummular Eczema: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery Neuromuscular Disorders in Left Ventricular Hypertrabeculation/Noncompaction
Current Pharmaceutical Design Inflammatory Reactions and Hydrocortisone in the Setting of Cardiac Surgery: An Overview
Cardiovascular & Hematological Agents in Medicinal Chemistry Drug Therapy Aimed at Adenylyl Cyclase to Regulate Cyclic Nucleotide Signaling
Endocrine, Metabolic & Immune Disorders - Drug Targets Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics
Endocrine, Metabolic & Immune Disorders - Drug Targets Neuronal Response of Peroxisomal and Peroxisome-Related Proteins to Chronic and Acute Aβ Injury
Current Alzheimer Research Longitudinal Association between White Matter Hyperintensities and White Matter Beta-Amyloid Deposition in Cognitively Unimpaired Elderly
Current Alzheimer Research